Chapter 8 - Nanotechnological approaches toward cancer chemotherapy
Abstract
A major focus of nanotechnology for cancer chemotherapy is to make use of drug-loaded nanoparticles (NPs), nanospheres, and nanocapsules to deliver the drug to a particular organ/tissue, avoiding off-site toxicity. Drug-loaded magnetic/fluorescent NPs are generally used to track their targeted delivery and distribution. Researchers attempt to target cancers by either passive targeting, that is, by using NPs that are specific for organs merely by their physiochemical properties or by active targeting, that is, by tethering NPs with monoclonal antibodies/ligands for single receptor or multiple receptors that are overexpressed in cancers. These modifications on NPs cause changes in their physiological parameters, such as blood-residence time, overcoming drug resistance, cellular uptake, and in physiochemical properties, such as drug payload, drug-releasing mechanisms, and so forth. Interestingly, pharmacokinetics and pharmacodynamics of various standard drugs are known to be generally improved in the case when biodegradable NPs are used, vis-a-vis the nonbiodegradable NPs. Pharmacotoxicology studies also give an insight on the safety of these NPs. In this chapter, we attempt to present an in-depth insight into the delivery and economic aspects of biodegradable and nonbiodegradable NPs, and discuss the gaps that exist between lab-scale and commercial potential of therapy using them.
References (0)
Cited by (14)
Recent progress in micro and nano-encapsulation techniques for environmental applications: A review
2023, Results in EngineeringIn recent years, micro- and nano-encapsulation methods have received considerable interest in the field of environmental research. These simple coating approaches retain the active material of interest inside a semi-permeable membrane or carrier matrix, which allows the transfer of materials between the matrix and the reaction medium. This enables the development of particles with a controlled or triggered-release mechanism. The use of pH, temperature and pressure-responsive agents is commonly employed to regulate the release of core material from encapsulated particles. Diverse applications, from water treatment to energy storage and agricultural practices, have seen the use of encapsulated materials especially in the micro and nano size range. Within the water treatment sector, studies with encapsulated materials have shown improved stability and reusability of various adsorbents for pollutant removal. However, challenges remain in separating encapsulated metal and nonmetal-based matrix-type composites from the aqueous phase. Major applications of encapsulated materials in the energy sector involve their use in different energy storage systems such as phase change materials (PCMs). Encapsulation of PCMs in a suitable shell material provides a large surface area and excellent thermal properties and helps overcome leakage problems associated with conventional PCMs. Within the agriculture domain, encapsulated particles provide controlled and extended delivery of agrochemicals at target site and protect the core materials from harsh environmental conditions. Hydrogel-based products improve sustainability in agriculture by conserving water needs. Overall, this review aims to provide a comprehensive overview of encapsulation synthesis techniques, their merits and challenges, as well as highlight the applications and future prospects of encapsulated materials within the environmental domain.
Nanomedicine: A pragmatic approach for tackling melanoma skin cancer
2023, Journal of Drug Delivery Science and TechnologyMelanoma is the most aggressive form of skin cancer and its annual incidence rates are increasing globally. Though chemotherapy, radiotherapy, immunotherapy and targeted therapy have significantly improved treatment outcomes, toxic effects and resistance are associated with these therapies. The ongoing research on therapeutically innovative and effective treatment strategies for such cancers led to the advancement of functional nanocarriers. These nanoplatforms can overcome the challenges linked with existing approaches, such as aimless distribution, unwanted off-target effects and suboptimal efficacy. This review summarizes current breakthroughs in the targeted delivery of nanotherapeutics for melanoma therapy. Different nanocarriers based on lipids, polymers and inorganic materials targeting melanoma are the main spotlights. Moreover, the role of nanomedicine in photodynamic therapy, photothermal therapy and the efficient delivery of genes and natural therapeutics for melanoma treatment is also highlighted.
AR13 peptide-conjugated liposomes improve the antitumor efficacy of doxorubicin in mice bearing C26 colon carcinoma; in silico, in vitro, and in vivo study
2023, Toxicology and Applied PharmacologyCurrently, liposomes have emerged as efficient and safer nano-carriers for targeted therapy in different cancers. This work aimed to employ PEGylated liposomal doxorubicin (Doxil®/PLD), modified with AR13 peptide, to target Muc1 on the surface of colon cancerous cells.
We performed molecular docking and simulation studies (using Gromacs package) of AR13 peptide against Muc1 to analyze and visualize the peptide-Muc1 binding combination. For in vitro analysis, the AR13 peptide was post–inserted into Doxil® and verified by TLC, 1H NMR, and HPLC techniques. The zeta potential, TEM, release, cell uptake, competition assay, and cytotoxicity studies were performed. In vivo antitumor activities and survival analysis on mice bearing C26 colon carcinoma were studied.
Results showed that after 100 ns simulation, a stable complex between AR13 and Muc1 formed, and molecular dynamics analysis confirmed this interaction. In vitro analysis demonstrated significant enhancement of cellular binding and cell uptake.
The results of in vivo study on BALB/c mice bearing C26 colon carcinoma, revealed an extended survival time to 44 days and higher tumor growth inhibition compared to Doxil®. Thus, the AR13 peptide could be explored as a potent ligand for Muc1, improving therapeutic antitumor efficiency in colon cancer cells.
An overview on nanocarriers
2022, Nanocarriers for Drug-Targeting Brain TumorsNanotechnology is emerging as a new technological revolution concerned with fabricating things, typically materials and devices at molecular or atomic level. Nanocarriers are nanosized materials widely used as delivery systems to transport therapeutic agents to targeted sites in the body. The effectiveness of the treatment can be improved by the usage of various nanocarriers such as polymeric nanoparticles, lipid-based carriers, gold nanoparticles, dendrimers, carbon tubes, etc. The choice of employing such carrier systems is dependent on the attributes (e.g., charge, size, solubility, etc.) of the bioactive substances, efficacy and safety of the bioactive-carrier complex, together with its application and the administration method of the complexes to the systemic circulation. This chapter may aid in providing a basic understanding of different types of nanocarriers, their applications, preparation techniques, and evaluation techniques, and of various nanocarriers targeting the brain and some natural products in nanocarriers.
Dendrimers toward Translational Nanotherapeutics: Concise Key Step Analysis
2020, Bioconjugate ChemistryThe goal of nanomedicine is to address specific clinical problems optimally, to fight human diseases, and to find clinical relevance to change clinical practice. Nanomedicine is poised to revolutionize medicine via the development of more precise diagnostic and therapeutic tools. The field of nanomedicine encompasses numerous features and therapeutic disciplines. A plethora of nanomolecular structures have been engineered and developed for therapeutic applications based on their multitasking abilities and the wide functionalization of their core scaffolds and surface groups. Within nanoparticles used for nanomedicine, dendrimers as well polymers have demonstrated strong potential as nanocarriers, therapeutic agents, and imaging contrast agents. In this review, we present and discuss the different criteria and parameters to be addressed to prepare and develop druggable nanoparticles in general and dendrimers in particular. We also describe the major requirements, included in the preclinical and clinical roadmap, for NPs/dendrimers for the preclinical stage to commercialization. Ultimately, we raise the clinical translation of new nanomedicine issues.
Anti-aging Strategies and Topical Delivery of Biopolymer-based Nanocarriers for Skin Cancer Treatment
2024, Current Aging Science